Observational study For Investigating the ability of Recuperation of work/ house work State with Tocilizumab (Actemra) SubCutaneous treatment in biologics-naive RA patients

Trial Profile

Observational study For Investigating the ability of Recuperation of work/ house work State with Tocilizumab (Actemra) SubCutaneous treatment in biologics-naive RA patients

Completed
Phase of Trial: Phase IV

Latest Information Update: 15 Dec 2017

At a glance

  • Drugs Tocilizumab (Primary) ; Disease-modifying antirheumatics
  • Indications Rheumatoid arthritis
  • Focus Therapeutic Use
  • Acronyms FIRST ACT-SC
  • Most Recent Events

    • 15 Dec 2017 Status changed from recruiting to completed, based on the results presented at the 81st American College of Rheumatology and the 52nd Association of Rheumatology Health Professionals Annual Scientific Meeting.
    • 08 Nov 2017 Primary endpoint (Change in percent overall work impairment) has not been met, according to results presented at the 81st American College of Rheumatology and the 52nd Association of Rheumatology Health Professionals Annual Scientific Meeting.
    • 08 Nov 2017 Results presented at the 81st American College of Rheumatology and the 52nd Association of Rheumatology Health Professionals Annual Scientific Meeting.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top